Erythropoietic therapy: cost efficiency and reimbursement
- PMID: 17687067
- DOI: 10.2146/ajhp070246
Erythropoietic therapy: cost efficiency and reimbursement
Abstract
Purpose: The practice of blood conservation is aimed at improving patient outcomes by avoiding allogeneic transfusions via a coordinated multidisciplinary, multipronged approach. The numerous blood conservation techniques and transfusion alternatives now available are described.
Summary: Ongoing concerns exist regarding the availability of the nation's and the world's blood supply. In addition, the number of measures required to ensure blood safety has led to increases in the price of blood and blood products over the past 10-15 years. Moreover, blood transfusion carries inherent risks even under the most favorable circumstances. Investigations have established that injudicious transfusion is associated with development of ventilator-associated pneumonia, nosocomial infection, and organ dysfunction. Because most single blood-conservation techniques reduce blood usage by a mere 1-2 units, a series of integrated conservation approaches are required. These include preoperative autologous donation, use of erythropoietic agents, blood conservation techniques such as acute normovolemic hemodilution, individualized assessment of anemia tolerance, implementation of conservative transfusion thresholds, meticulous surgical techniques, and judicious use of phlebotomy and pharmacologic agents for limiting blood loss. Erythropoietic agents such as epoetin alfa have been used successfully to increase hemoglobin and decrease transfusion requirements, and are appropriate when used in advance of elective surgical procedures. Acquisition costs of erythropoietic stimulating agents versus costs of blood justify economic evaluation by hospitals to make the most cost-effective choice under current economic constraints.
Conclusion: Initiating a blood management program requires planning and support from those who are concerned about blood usage reduction and outcomes improvement. Launching a vigorous and ongoing educational program to raise awareness about the risks and hazards associated with blood transfusion is an important step in helping to reshape the medical staffs' attitudes about transfusion and the most cost-effective way to achieve clinical goals.
Similar articles
-
Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial.Pharmacoeconomics. 2006;24(5):479-94. doi: 10.2165/00019053-200624050-00006. Pharmacoeconomics. 2006. PMID: 16706573 Clinical Trial.
-
Perioperative blood management practices in elective orthopaedic surgery.J Am Acad Orthop Surg. 2002 Nov-Dec;10(6):393-400. doi: 10.5435/00124635-200211000-00003. J Am Acad Orthop Surg. 2002. PMID: 12470041 Review.
-
Erythropoietic agents for anemia of critical illness.Am J Health Syst Pharm. 2008 Mar 15;65(6):540-6. doi: 10.2146/ajhp070225. Am J Health Syst Pharm. 2008. PMID: 18319499 Review.
-
[Blood conservation approaches in orthopedic surgery].Transfus Clin Biol. 2008 Nov;15(5):294-302. doi: 10.1016/j.tracli.2008.09.024. Epub 2008 Oct 18. Transfus Clin Biol. 2008. PMID: 18930421 Review. French.
-
Objectives and limitations of bloodless medical care.Curr Opin Hematol. 2006 Nov;13(6):462-70. doi: 10.1097/01.moh.0000245692.32085.bd. Curr Opin Hematol. 2006. PMID: 17053460 Review.
Cited by
-
Big data modeling to predict platelet usage and minimize wastage in a tertiary care system.Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11368-11373. doi: 10.1073/pnas.1714097114. Epub 2017 Oct 9. Proc Natl Acad Sci U S A. 2017. PMID: 29073058 Free PMC article.
-
A model of erythropoiesis in adults with sufficient iron availability.J Math Biol. 2013 May;66(6):1209-40. doi: 10.1007/s00285-012-0530-0. Epub 2012 Apr 18. J Math Biol. 2013. PMID: 22526838
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous